HIV Citation List: August 31 - September 13, 2012

PubMed citations

1.A Multi-functional Peptide as an HIV-1 Entry Inhibitor Based on Self-concentration, Recognition, and Covalent Attachment. Zhao, L., P. Tong, Y.X. Chen, Z.W. Hu, K. Wang, Y.N. Zhang, D.S. Zhao, L.F. Cai, K.L. Liu, Y.F. Zhao, and Y.M. Li. Organic and Biomolecular Chemistry, 2012. 10(32): p. 6512-6520. PMID[22760295].

[PubMed].HIV_0817-083012.

2.Bifunctional Cd4-Dc-sign Fusion Proteins Demonstrate Enhanced Avidity to gp120 and Inhibit HIV-1 Infection and Dissemination. Du, T., K. Hu, J. Yang, J. Jin, C. Li, D. Stieh, G.E. Griffin, R.J. Shattock, and Q. Hu. Antimicrobial Agents and Chemotherapy, 2012. 56(9): p. 4640-4649. PMID[22687513]. [PubMed]. HIV_0831-091312.

3.One Pot Efficient Diversity Oriented Synthesis of Polyfunctional Styryl Thiazolopyrimidines and Their Bio-evaluation as Antimalarial and anti-HIV Agent. Fatima, S., A. Sharma, R. Saxena, R. Tripathi, S.K. Shukla, S.K. Pandey, and R.P. Tripathi. European Journal of Medicinal Chemistry, 2012. 55: p. 195-204. PMID[22871486].

[PubMed]. HIV_0831-091312.

4.Feglymycin, a Unique Natural Bacterial Antibiotic Peptide, Inhibits HIV Entry by Targeting the Viral Envelope Protein gp120. Ferir, G., A. Hanchen, K.O. Francois, B. Hoorelbeke, D. Huskens, F. Dettner, R.D. Sussmuth, and D. Schols. Virology, 2012. [Epub ahead of print]; PMID[22959895].

[PubMed]. HIV_0831-091312.

5.Alkyl Hydroxybenzoic Acid Derivatives that Inhibit HIV-1 Protease Dimerization. Flausino, O.A., L. Dufau, L.O. Regasini, M.S. Petronio, D.H. Silva, T. Rose, V.S. Bolzani, and M. Reboud-Ravaux. Current Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22963666].

[PubMed]. HIV_0831-091312.

6.Antiviral Properties against HIV of Water Soluble Copper Carbosilane Dendrimers and Their EPR Characterization. Galan, M., J. Sanchez-Rodriguez, M. Cangiotti, S. Garcia-Gallego, J.L. Jimenez, R. Gomez, M.F. Ottaviani, M.A. Munoz-Fernandez, and F.J. de la Mata. Current Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22963631].

[PubMed].HIV_0831-091312.

7.Cytolytic Nanoparticles Attenuate HIV-1 Infectivity. Hood, J.L., A.P. Jallouk, N. Campbell, L. Ratner, and S.A. Wickline. Antiviral Therapy, 2012. [Epub ahead of print]; PMID[22954649].

[PubMed]. HIV_0831-091312.

8.Design, Practical Synthesis, and Biological Evaluation of Novel 6-(pyrazolylmethyl)-4-quinoline-3-carboxylic Acid Derivatives as HIV-1 Integrase Inhibitors. Hu, L., S. Yan, Z. Luo, X. Han, Y. Wang, Z. Wang, and C. Zeng. Molecules, 2012. 17(9): p. 10652-10666. PMID[22955454].

[PubMed]. HIV_0831-091312.

9.Carbamoyl Pyridone HIV-1 Integrase Inhibitors. Molecular Design and Establishment of an Advanced Two-metal Binding Pharmacophore. Kawasuji, T. Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22963135].

[PubMed]. HIV_0831-091312.

10.Gold Nanoparticles as a HIV Entry Inhibitor. Kumar, S.V. and S. Ganesan. Current HIV Research, 2012. [Epub ahead of print]; PMID[22954307].

[PubMed]. HIV_0831-091312.

11.The Antiviral Activity and Mechanism of Action of (S)-[3-Hydroxy-2-(phosphonomethoxy)propyl] (HPMP) Nucleosides. Magee, W.C. and D.H. Evans. Antiviral Research, 2012. [Epub ahead of print]; PMID[22960154].

[PubMed]. HIV_0831-091312.

12.Concise Synthesis and anti-HIV Activity of Pyrimido[1,2-C][1,3]benzothiazin-6-imines and Related Tricyclic Heterocycles. Mizuhara, T., S. Oishi, H. Ohno, K. Shimura, M. Matsuoka, and N. Fujii. Organic and Biomolecular Chemistry, 2012. 10(33): p. 6792-6802. PMID[22829059].

[PubMed]. HIV_0831-091312.

13.Novel Method to Assess Antiretroviral Target Trough Concentrations Using in Vitro Susceptibility Data. Acosta, E.P., K.L. Limoli, L. Trinh, N.T. Parkin, J.R. King, J.M. Weidler, I. Ofotokun, and C.J. Petropoulos. Antimicrobial Agents and Chemotherapy, 2012. [Epub ahead of print]; PMID[22964257]. [PubMed]. HIV_0831-091312.

14.Synthesis and Anti-HIV Activities of Symmetrical Dicarboxylate Esters of Dinucleoside Reverse Transcriptase Inhibitors. Agarwal, H.K., K.W. Buckheit, R.W. Buckheit, Jr., and K. Parang. Bioorganic & Medicinal Chemistry Letters, 2012. 22(17): p. 5451-5454. PMID[22858097].

[PubMed]. HIV_0831-091312.

15.Synthesis and Evaluation of Hybrid Drugs for a Potential HIV/AIDS-Malaria Combination Therapy. Aminake, M.N., A. Mahajan, V. Kumar, R. Hans, L. Wiesner, D. Taylor, C. de Kock, A. Grobler, P.J. Smith, M. Kirschner, A. Rethwilm, G. Pradel, and K. Chibale. Bioorganic & Medicinal Chemistry, 2012. 20(17): p. 5277-5289. PMID[22858300].

[PubMed]. HIV_0831-091312.

16.Covalent Fusion Inhibitors Targeting HIV-1 gp41 Deep Pocket. Bai, Y., H. Xue, K. Wang, L. Cai, J. Qiu, S. Bi, L. Lai, M. Cheng, S. Liu, and K. Liu. Amino Acids, 2012. [Epub ahead of print]; PMID[22961335].

[PubMed]. HIV_0831-091312.

17.Anti-HIV-1 and Cytotoxicity of the Alkaloids of Erythrina abyssinica Lam. Growing in Sudan. Mohammed, M.M., N.A. Ibrahim, N.E. Awad, A.A. Matloub, A.G. Mohamed-Ali, E.E. Barakat, A.E. Mohamed, and P.L. Colla. Natural Product Research, 2012. 26(17): p. 1565-1575. PMID[21936641].

[PubMed]. HIV_0831-091312.

18. In Vitro Evolution of an HIV Integrase Binding Protein from a Library of C-terminal Domain Gammas-crystallin Variants. Moody, I.S., S.C. Verde, C.M. Overstreet, W. Edward Robinson, Jr., and G.A. Weiss. Bioorganic & Medicinal Chemistry Letters, 2012. 22(17): p. 5584-5589. PMID[22858140]. [PubMed]. HIV_0831-091312.

19. Synthesis and anti-HIV Properties of New Carbamate Prodrugs of AZT. Solyev, P.N., A.V. Shipitsin, I.L. Karpenko, D.N. Nosik, L.B. Kalnina, S.N. Kochetkov, M.K. Kukhanova, and M.V. Jasko. Chemical Biology and Drug Design, 2012. [Epub ahead of print]; PMID[22958368].

[PubMed]. HIV_0831-091312.

20.Neutralizing Antibodies Inhibit HIV-1 Transfer from Primary Dendritic Cells to Autologous CD4 T-lymphocytes. Su, B., K. Xu, A. Lederle, M. Peressin, M.E. Biedma, G. Laumond, S. Schmidt, T. Decoville, A. Proust, M. Lambotin, V. Holl, and C. Moog. Blood, 2012. [Epub ahead of print]; PMID[22955927].

[PubMed]. HIV_0831-091312.

21. Discovery of Novel Low-molecular-weight HIV-1 Inhibitors Interacting with Cyclophilin a Using in Silico Screening and Biological Evaluations. Tian, Y.S., C. Verathamjamras, N. Kawashita, K. Okamoto, T. Yasunaga, K. Ikuta, M. Kameoka, and T. Takagi. Journal of Molecular Modeling, 2012. [Epub ahead of print]; PMID[22949064].

[PubMed]. HIV_0831-091312.

22.Anti HIV-1 Agents 6. Synthesis and anti-HIV-1 Activity of Indolyl Glyoxamides. Wang, Y., N. Huang, X. Yu, L.M. Yang, X.Y. Zhi, Y.T. Zheng, and H. Xu. Medicinal Chemistry, 2012. 8(5): p. 831-833. PMID[22741604].

[PubMed]. HIV_0831-091312.

23.Benzophenone Glycosides and Epicatechin Derivatives from Malania oleifera. Wu, X.D., J.T. Cheng, J. He, X.J. Zhang, L.B. Dong, X. Gong, L.D. Song, Y.T. Zheng, L.Y. Peng, and Q.S. Zhao. Fitoterapia, 2012. 83(6): p. 1068-1071. PMID[22609684].

[PubMed]. HIV_0831-091312.

ISI Web of Knowledge Citations

24. Antiretroviral Agents Effectively Block HIV Replication after Cell-to-Cell Transfer. Permanyer, M., E. Ballana, A. Ruiz, R. Badia, E. Riveira-Munoz, E. Gonzalo, B. Clotet, and J.A. Este. Journal of Virology, 2012. 86(16): p. 8773-8780. ISI[000307198300043].

[WOS]. HIV_0831-091312.

25.A Bitter Plant with a Sweet Future? A Comprehensive Review of an Oriental Medicinal Plant: Andrographis Paniculata. Subramanian, R., M.Z. Asmawi, and A. Sadikun. Phytochemistry Reviews, 2012. 11(1): p. 39-75. ISI[000307386900003].

[WOS]. HIV_0831-091312.

26.Inhibiting Early-stage Events in HIV-1 Replication by Small-Molecule Targeting of the HIV-1 Capsid. Kortagere, S., N. Madani, M.K. Mankowski, A. Schon, I. Zentner, G. Swaminathan, A. Princiotto, K. Anthony, A. Oza, L.J. Sierra, S.R. Passic, X.Z. Wang, D.M. Jones, E. Stavale, F.C. Krebs, J. Martin-Garcia, E. Freire, R.G. Ptak, J. Sodroski, S. Cocklin, and A.B. Smith. Journal of Virology, 2012. 86(16): p. 8472-8481. ISI[000307198300013].

[WOS]. HIV_0831-091312.